ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
6.91
-0.40 (-5.47%)
At close: Nov 20, 2026, 4:00 PM EST
6.98
+0.07 (1.01%)
After-hours: Nov 20, 2026, 7:50 PM EST
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $12.08M in the quarter ending September 30, 2026, with 36.27% growth. This brings the company's total for the last twelve months to $45.49M, up 32.51% year-over-year. In the year 2025, ClearPoint Neuro had annual revenue of $36.97M with 17.78% growth. That makes ClearPoint Neuro the 28,688th largest company in the world by revenue and 3,841st in the United States.
Revenue (ttm)
$45.49M
Revenue Growth
+32.51%
P/S Ratio
4.87
Revenue / Employee
$264,494
Employees
172
Market Cap
221.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.97M | 5.58M | 17.78% |
| Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
| Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
| Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
| Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
| Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
| Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
| Dec 31, 2018 | 7.35M | -26.26K | -0.36% |
| Dec 31, 2017 | 7.38M | 1.63M | 28.35% |
| Dec 31, 2016 | 5.75M | 1.16M | 25.15% |
| Dec 31, 2015 | 4.59M | 989.71K | 27.46% |
| Dec 31, 2014 | 3.60M | -326.09K | -8.30% |
| Dec 31, 2013 | 3.93M | -1.13M | -22.29% |
| Dec 31, 2012 | 5.06M | 1.24M | 32.48% |
| Dec 31, 2011 | 3.82M | 1.15M | 43.03% |
| Dec 31, 2010 | 2.67M | 69.45K | 2.67% |
| Dec 31, 2009 | 2.60M | 650.00K | 33.33% |
| Dec 31, 2008 | 1.95M | 1.83M | 1,460.00% |
| Dec 31, 2007 | 125.00K | -842.83K | -87.08% |
| Dec 31, 2006 | 967.83K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 835.41M |
| Viemed Healthcare | 310.37M |
| Treace Medical Concepts | 203.35M |
| InfuSystem Holdings | 144.44M |
| RxSight | 121.83M |
| NeuroPace | 106.75M |
| Standard BioTools | 84.43M |
| Electromed | 75.57M |
CLPT News
- 3 days ago - ClearPoint Neuro files $200M mixed securities shelf - TheFly
- 3 days ago - ClearPoint Neuro Registration statement: Registration filing - Filings
- 23 days ago - ClearPoint Neuro price target lowered to $18 from $22 at Stifel - TheFly
- 24 days ago - ClearPoint Neuro Earnings Call Transcript: Q3 2026 - Transcripts
- 24 days ago - ClearPoint Neuro Earnings release: Q3 2026 - Filings
- 24 days ago - ClearPoint Neuro Quarterly report: Q3 2026 - Filings
- 24 days ago - ClearPoint Neuro Slides: Investor presentation - Filings
- 5 weeks ago - ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026 - Accesswire